Zifeng Yang

9.2k total citations · 2 hit papers
183 papers, 4.6k citations indexed

About

Zifeng Yang is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Zifeng Yang has authored 183 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Epidemiology, 60 papers in Infectious Diseases and 37 papers in Immunology. Recurrent topics in Zifeng Yang's work include Influenza Virus Research Studies (73 papers), Respiratory viral infections research (44 papers) and SARS-CoV-2 and COVID-19 Research (31 papers). Zifeng Yang is often cited by papers focused on Influenza Virus Research Studies (73 papers), Respiratory viral infections research (44 papers) and SARS-CoV-2 and COVID-19 Research (31 papers). Zifeng Yang collaborates with scholars based in China, Macao and Hong Kong. Zifeng Yang's co-authors include Nanshan Zhong, Runfeng Li, Haiming Jiang, Jin Zhao, Zhi‐Hong Jiang, Yutao Wang, Beixian Zhou, Qinhai Ma, Wenbo Huang and Zhenhua Jia and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Zifeng Yang

175 papers receiving 4.5k citations

Hit Papers

Lianhuaqingwen exerts anti-viral and anti-inflammatory ac... 2020 2026 2022 2024 2020 2020 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
    2020 495 citations Runfeng Li, Weiqi Pan et al. profile →
  2. Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial
    2020 338 citations Zifeng Yang, Jingyi Liang et al. Phytomedicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zifeng Yang China 37 1.4k 1.3k 1.3k 804 681 183 4.6k
Cheng‐Wen Lin Taiwan 44 1.4k 1.0× 2.1k 1.6× 564 0.4× 508 0.6× 413 0.6× 197 5.9k
Liang Lin Taiwan 37 585 0.4× 1.9k 1.5× 960 0.8× 701 0.9× 552 0.8× 155 5.4k
Usman Ali Ashfaq Pakistan 36 795 0.6× 2.1k 1.6× 773 0.6× 461 0.6× 249 0.4× 193 4.5k
Wu Zhong China 27 2.5k 1.8× 1.4k 1.1× 673 0.5× 334 0.4× 261 0.4× 116 5.4k
Polrat Wilairatana Thailand 45 655 0.5× 1.2k 0.9× 453 0.4× 1.1k 1.3× 266 0.4× 319 7.2k
Stephen J. Polyak United States 47 1.3k 0.9× 1.7k 1.3× 3.1k 2.4× 763 0.9× 128 0.2× 112 7.7k
Kimíyasu Shiraki Japan 37 2.5k 1.8× 1.2k 0.9× 4.0k 3.1× 502 0.6× 232 0.3× 158 7.4k
Mohamed A. Ali Egypt 42 2.0k 1.5× 791 0.6× 1.4k 1.1× 237 0.3× 277 0.4× 251 5.1k
Jie Yang China 34 476 0.3× 1.1k 0.9× 674 0.5× 219 0.3× 240 0.4× 170 4.0k
Amitava Dasgupta United States 39 1.2k 0.9× 2.1k 1.6× 668 0.5× 251 0.3× 209 0.3× 320 5.4k

Countries citing papers authored by Zifeng Yang

Since Specialization
Citations

This map shows the geographic impact of Zifeng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zifeng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zifeng Yang more than expected).

Fields of papers citing papers by Zifeng Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zifeng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zifeng Yang. The network helps show where Zifeng Yang may publish in the future.

Co-authorship network of co-authors of Zifeng Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Zifeng Yang. A scholar is included among the top collaborators of Zifeng Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zifeng Yang. Zifeng Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yang, Chunguang, Yang Wang, Haiping Zhou, et al.. (2025). Cathepsin S contributes to influenza-induced lung injury by driving inflammation, promoting apoptosis, and disrupting epithelial barrier integrity. Microbiology Spectrum. 14(1). e0112825–e0112825.
3.
4.
Chen, Xiaofei, Yu Song, Yiling Liu, et al.. (2024). A near-infrared emitting “off-on” fluorescent probe for bioimaging of Pd(Ⅱ) ions in living cells and mice. Analytica Chimica Acta. 1289. 342174–342174. 5 indexed citations
5.
6.
Chen, Xiaofei, et al.. (2024). Excitation energy transfer based naphthalimide-boron-dipyrromethene dyads as two-photon fluorescent probes for palladium(0) detection and live cell imaging. Sensors and Actuators B Chemical. 423. 136746–136746. 3 indexed citations
7.
Wang, Yang, Man Li, Lin Ma, et al.. (2024). A decavalent composite mRNA vaccine against both influenza and COVID-19. mBio. 15(9). e0066824–e0066824. 8 indexed citations
8.
9.
Zeng, Zhiqi, Jingyi Liang, Qianying Li, et al.. (2024). The Impact of Medical Resources and Oral Antiviral Drugs on SARS-CoV-2 Mortality — Hong Kong SAR, China, 2022. China CDC Weekly. 6(21). 469–477.
10.
11.
Kang, Min, Xiaohua Tan, Cheng Xiao, et al.. (2023). The impact of pre‐existing influenza antibodies and inflammatory status on the influenza vaccine responses in older adults. Influenza and Other Respiratory Viruses. 17(7). e13172–e13172. 4 indexed citations
12.
Li, Runfeng, Xiaobo Zhou, Hongxia Zhou, et al.. (2021). Novel Fatty Acid in Cordyceps Suppresses Influenza A (H1N1) Virus-Induced Proinflammatory Response Through Regulating Innate Signaling Pathways. ACS Omega. 6(2). 1505–1515. 14 indexed citations
13.
Zhao, Jin, et al.. (2021). Chaiqin Qingning Capsule Inhibits Influenza Virus Infection and Inflammation In Vitro and In Vivo. Evidence-based Complementary and Alternative Medicine. 2021. 1–9. 7 indexed citations
14.
Lei, Hui, Feng Ye, Xiaoqing Liu, et al.. (2020). SARS‐CoV‐2 environmental contamination associated with persistently infected COVID‐19 patients. Influenza and Other Respiratory Viruses. 14(6). 688–699. 60 indexed citations
15.
Shiu, Eunice Y. C., Wenbo Huang, Dan Ye, et al.. (2020). Frequent recovery of influenza A but not influenza B virus RNA in aerosols in pediatric patient rooms. Indoor Air. 30(5). 805–815. 11 indexed citations
16.
Zhao, Xin, Runfeng Li, Yang Zhou, et al.. (2018). Discovery of Highly Potent Pinanamine-Based Inhibitors against Amantadine- and Oseltamivir-Resistant Influenza A Viruses. Journal of Medicinal Chemistry. 61(12). 5187–5198. 27 indexed citations
17.
Herfst, Sander, Chris Ka Pun Mok, Judith M. A. van den Brand, et al.. (2018). Human Clade 2.3.4.4 A/H5N6 Influenza Virus Lacks Mammalian Adaptation Markers and Does Not Transmit via the Airborne Route between Ferrets. mSphere. 3(1). 46 indexed citations
18.
Li, Runfeng, Mark Zanin, Xueshan Xia, & Zifeng Yang. (2018). The tree shrew as a model for infectious diseases research. Journal of Thoracic Disease. 10(S9). S2272–S2279. 20 indexed citations
19.
Yang, Zifeng, Ziqiang Liu, Ruizhen Zeng, et al.. (2014). Epistatic analysis of the QTL on heading date in rice using single segment substitution lines.. Journal of the South China Agricultural University. 35(6). 24–28. 1 indexed citations
20.
Mo, Ziyao, Hongbo Zhao, Wenda Guan, et al.. (2011). Single and duplex fluorescence quantitative PCR for rapid detection of Legionella. 17(1). 61–65. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cheng‐Wen Lin Breakdown of academic impact, for papers by Liang Lin Breakdown of academic impact, for papers by Usman Ali Ashfaq Breakdown of academic impact, for papers by Wu Zhong Breakdown of academic impact, for papers by Polrat Wilairatana Breakdown of academic impact, for papers by Stephen J. Polyak Breakdown of academic impact, for papers by Kimíyasu Shiraki Breakdown of academic impact, for papers by Mohamed A. Ali Breakdown of academic impact, for papers by Jie Yang Breakdown of academic impact, for papers by Amitava Dasgupta
Rankless by CCL
2026